Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Alseres Pharmaceuticals Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 530,720 473,730
Cost of Goods Sold (COGS) incl. D&A - 58,598 40,751 - 1,186
COGS excluding D&A - 0 0 - 0
Depreciation & Amortization Expense 72,371 58,598 40,751 1,289 1,186
Depreciation 72,371 58,598 40,751 1,289 1,186
Amortization of Intangibles - - - 0 0
Gross Income - (58,598) (40,751) - 472,544
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 8.25M 3.06M 2.06M 1.74M 1.44M
Research & Development 3.7M 465,449 93,319 50,750 0
Other SG&A 4.55M 2.6M 1.96M 1.69M 1.44M
Other Operating Expense 0 0 0 0 0
Unusual Expense 1.5M (6.28M) (1.01M) 0 (405,026)
EBIT after Unusual Expense (1.5M) 6.28M 1.01M 0 405,026
Non Operating Income/Expense 1.57M 1,886 689 905 77,037
Non-Operating Interest Income 0 0 43,814 341 819
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 2.52M 2.64M 1.84M 434,551 454,662
Gross Interest Expense 2.52M 2.64M 1.84M 434,551 454,662
Interest Capitalized 0 0 0 0 0
Pretax Income (10.78M) 512,419 (2.88M) (1.65M) (941,529)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income (10.78M) 512,419 (2.88M) (1.65M) (941,529)
Minority Interest Expense 0 0 0 0 0
Net Income (10.78M) 512,419 (2.88M) (1.65M) (941,529)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (10.78M) 512,419 (2.88M) (1.65M) (941,529)
Preferred Dividends 0 369,282 0 0 0
Net Income Available to Common (10.78M) 143,137 (2.88M) (1.65M) (941,529)
EPS (Basic) (0.46) 0.01 (0.10) (0.05) (0.03)
Basic Shares Outstanding 23.36M 26.69M 29.63M 30.64M 30.64M
EPS (Diluted) (0.46) 0.00 (0.10) (0.05) (0.03)
Diluted Shares Outstanding 23.36M 31.59M 29.63M 30.64M 30.64M
EBITDA (8.25M) (3.06M) (2.06M) (1.21M) (968,563)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.